BWX Technologies (NYSE:BWXT) Announces Quarterly Earnings Results

BWX Technologies (NYSE:BWXT) released its quarterly earnings data on Monday. The technology company reported $1.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.17, Zacks reports. BWX Technologies had a net margin of 10.28% and a return on equity of 31.32%. The company had revenue of $885.84 million during the quarter, compared to analyst estimates of $837.47 million. During the same quarter in the prior year, the business earned $0.92 earnings per share. The business’s quarterly revenue was up 18.7% compared to the same quarter last year. BWX Technologies updated its FY 2026 guidance to 4.550-4.700 EPS.

Here are the key takeaways from BWX Technologies’ conference call:

• BWXT closed a record 2025 with revenue up 18%, Adjusted EBITDA up 15%, EPS up 20%, free cash flow up 16%, and a year-end backlog of $7.3 billion (up 15% YoY).
• Commercial operations drove the quarter — Q4 commercial revenue rose 95% (31% organic) and commercial backlog reached $1.7 billion (up 85% YoY), while BWXT Medical surpassed $100 million in annual revenue with continued double‑digit growth expected.
• Strategic M&A and investments accelerated capability and wins — the AOT and Kinectrics acquisitions supported awards including a $1.6 billion high‑purity depleted uranium contract and an owner’s‑engineer role for the AP1000 in Bulgaria, plus new facilities (Innovation Campus, Centrifuge facility, Digital Center) to scale advanced nuclear and special materials.
• Financial position strengthened — BWXT completed a $1.25 billion 0% convertible, increased liquidity to $1.7 billion, reduced interest costs, and guided 2026 to ~$3.75 billion revenue, Adjusted EBITDA $645–660M, EPS $4.55–4.70, and FCF $305–320M.
• Near‑term margin and cadence risks — government revenue/EBITDA were slightly down in Q4, new government programs begin at lower initial margins, and management expects ~55% of EBITDA to be back‑half weighted with Q1 EBITDA likely flat, implying short‑term pressure on margins and quarterly results.

BWX Technologies Trading Up 3.1%

Shares of BWXT opened at $204.49 on Wednesday. BWX Technologies has a one year low of $84.21 and a one year high of $220.57. The stock has a 50-day moving average price of $196.27 and a 200 day moving average price of $186.97. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.62 and a current ratio of 1.71. The company has a market capitalization of $18.70 billion, a P/E ratio of 57.28, a P/E/G ratio of 3.19 and a beta of 0.84.

BWX Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 27th. Investors of record on Wednesday, March 11th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.5%. This is a positive change from BWX Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Wednesday, March 11th. BWX Technologies’s payout ratio is presently 30.03%.

BWX Technologies News Summary

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: Q4 beat and healthy growth — BWXT reported Q4 EPS of $1.08 vs. a $0.91 consensus and revenue of $885.8M (above estimates); revenue rose ~19% year-over-year, and management called 2025 a record year. BWX Technologies Reports Fourth Quarter and Full Year 2025 Results
• Positive Sentiment: Upgraded 2026 guidance — BWXT set FY2026 EPS guidance of $4.55–$4.70 and revenue guidance around $3.8B, well above prior consensus, which is a primary catalyst supporting the stock rally. Guidance Press Release
• Positive Sentiment: Backlog and nuclear market momentum — management highlighted a large, growing backlog (reports cite ~50% backlog growth) and expanding commercial and defense nuclear work (SMRs, life‑extension contracts, enrichment awards), supporting multi‑year revenue visibility. BWX Technologies’ Stock Jumps. Its Nuclear Business Is Growing.
• Positive Sentiment: Analyst model changes — Northland Securities raised its Q2 and Q3 2026 EPS estimates and published an FY2027 view of $5.11; incremental analyst upward revisions support momentum (mixed on Q1). (Northland research note)
• Positive Sentiment: Dividend bump — BWXT raised its quarterly dividend to $0.27 (8% increase), a sign of confidence in cash flow that can attract income-focused investors. (Company announcement)
• Neutral Sentiment: Mixed near-term estimates — Northland trimmed its Q1 2026 estimate modestly (from $0.95 to $0.91) even as it lifted later‑year forecasts; a slight near-term pivot but overall outlook was upgraded.
• Neutral Sentiment: Positive press and analyst coverage — multiple outlets (Zacks, Benzinga) highlighted the beat and backlog; media attention helps visibility but is secondary to the results. Zacks Coverage
• Negative Sentiment: Valuation and expectations — the stock trades at a premium (P/E roughly mid‑50s on trailing numbers), so much of the upside depends on execution against elevated FY2026–FY2027 expectations; valuation could limit near‑term gains if guidance execution slips.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on BWXT shares. Zacks Research raised shares of BWX Technologies from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Northland Securities set a $225.00 target price on BWX Technologies in a research report on Tuesday, November 4th. CJS Securities upgraded BWX Technologies to a “strong-buy” rating in a research note on Friday, December 12th. Weiss Ratings downgraded BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 26th. Finally, Truist Financial set a $205.00 price target on BWX Technologies in a research report on Friday, January 9th. Three analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $199.20.

Insider Transactions at BWX Technologies

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $203.26, for a total value of $2,032,600.00. Following the transaction, the chief executive officer directly owned 177,594 shares of the company’s stock, valued at $36,097,756.44. This represents a 5.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.47% of the stock is owned by corporate insiders.

Institutional Trading of BWX Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in BWXT. WFA of San Diego LLC bought a new position in BWX Technologies during the 2nd quarter valued at $29,000. Ancora Advisors LLC acquired a new stake in shares of BWX Technologies in the 3rd quarter valued at about $49,000. Quarry LP raised its stake in shares of BWX Technologies by 158.3% in the 4th quarter. Quarry LP now owns 359 shares of the technology company’s stock valued at $62,000 after purchasing an additional 220 shares in the last quarter. Rakuten Securities Inc. lifted its position in shares of BWX Technologies by 309.7% during the second quarter. Rakuten Securities Inc. now owns 463 shares of the technology company’s stock worth $67,000 after purchasing an additional 350 shares during the last quarter. Finally, Greenline Wealth Management LLC acquired a new position in BWX Technologies in the fourth quarter worth about $69,000. Institutional investors own 94.39% of the company’s stock.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.